SCHEMBL22136186

SCHEMBL22136186

C[C@]12CC[C@H]3[C@@H](CC[C@@H]4CCCC[C@@H]43)[C@@H]1CC[C@@H]2C(=O)O

nearest known ligand 0.56

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
GABRP O00591 18/20 0.56
GABRD O14764 18/20 0.56
GABRA1 P14867 18/20 0.56
GABRB1 P18505 18/20 0.56
GABRG2 P18507 18/20 0.56
GABRB3 P28472 18/20 0.56
GABRA5 P31644 18/20 0.56
GABRA3 P34903 18/20 0.56
GABRA2 P47869 18/20 0.56
GABRB2 P47870 18/20 0.56
GABRA4 P48169 18/20 0.56
GABRE P78334 18/20 0.56
GABRA6 Q16445 18/20 0.56
GABRG1 Q8N1C3 18/20 0.56
GABRG3 Q99928 18/20 0.56
GABRQ Q9UN88 18/20 0.56
SHBG P04278 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3115466 0.89 GABRA1 (0.71) GABRPGABRDGABRA1GABRB1GABRG2
SCHEMBL7315413 0.89 GABRA1 (0.71) GABRPGABRDGABRA1GABRB1GABRG2
SCHEMBL22033067 0.89 GABRA1 (0.71) GABRPGABRDGABRA1GABRB1GABRG2
SCHEMBL22136187 0.87 GABRP (0.55) GABRPGABRDGABRA1GABRB1GABRG2
SCHEMBL22516226 0.83 GABRA1 (0.81) GABRPGABRDGABRA1GABRB1GABRG2
SCHEMBL16190892 0.83 GABRA1 (0.81) GABRPGABRDGABRA1GABRB1GABRG2
SCHEMBL19777258 0.83 GABRP (0.54) GABRPGABRDGABRA1GABRB1GABRG2
SCHEMBL17792263 0.83 GABRA1 (0.81) GABRPGABRDGABRA1GABRB1GABRG2
SCHEMBL17544857 0.82 HSD11B1 (0.43) GABRPGABRDGABRA1GABRB1GABRG2
SCHEMBL10600842 0.82 GABRD (0.49) GABRPGABRDGABRA1GABRB1GABRG2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2020132504-A1 3.ALPHA.-HYDROXY-17.BETA.-AMIDE NEUROACTIVE STEROIDS AND COMPOSITIONS THEREOF SAGE THERAPEUTICS, INC. (US) 2020-06-25 WO disclosed